THOMSON ADDS ENCODER OPTION TO STEPPER MOTOR LINEAR ACTUATOR ONLINE SELECTION TOOL
Reading Time: 3 minutes Editorial Contact: Priya Sharma – +44 (0) 203 965 7415Company Contact: Kevin Bastian – +1 630 694 3342 Please quote the following contact information when publishing:Tel.: 540.633.3549, Fax: 540.633.0294, www.thomsonlinear.com; Thomson@regalrexnord.com 01.08.2024, DOWNERS GROVE, IL – Thomson Industries, Inc., a
Symrise’s recommended offer to the shareholders of Probi expires soon; regulatory approval received
Reading Time: 6 minutes The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, any jurisdiction in which the making of
Nordea Bank Abp: Repurchase of own shares on 10.01.2025
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares10.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
SlotsRank Explores Top Branded Slot Games
Reading Time: 2 minutes Stockholm, Sweden – January 2025 – SlotsRank, a renowned platform for online slot reviews and rankings, has released its latest insights into branded slot games, a category redefining the online casino landscape. By combining globally recognized franchises with innovative slot mechanics, branded
Fitch Affirms Investment Grade Rating of ’BBB-’ for Heimstaden Bostad, Raised Outlook to Stable
Reading Time: < 1 minute Fitch affirms Heimstaden Bostad’s Long-Term Issuer Default rating (IDR) of ‘BBB-‘ and raises the Outlook to Stable from Negative. Co-CEO Christian Fladeland comments: “The stable outlook validates that Heimstaden Bostad continues to deliver on its base case performance which
Sobi’s full year 2024 revenue higher than previous estimate
Reading Time: 2 minutes Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing approximately 19% growth at constant exchange rate (CER) (1). Adjusted EBITA margin (1,2)
STENOCARE A/S announces guarantee commitments in ongoing rights issue
Reading Time: 3 minutes STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“Stenocare” or the “Company”) announces that the Company has received a legally binding guarantee commitment of 2 mDKK from Exelity AB, securing approximately 9.9 percent of the total issue corresponding to approximately
2025 Roadmap: Boomerang Partners Targets Growth in iGaming
Reading Time: 2 minutes Boomerang Partners has shared its plans for 2025. This rapidly growing global company is preparing for new products and global expansion. After a successful 2024, it is ready to strengthen its position in iGaming with a key focus on sports betting. Boomerang
Invitation to monthly digital events and presentations of quarterly report
Reading Time: < 1 minute Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during
UNION therapeutics to present at the Dermatology Summit 2025, opening the week of the 43rd Annual J.P. Morgan Health Care Conference
Reading Time: 2 minutes Hellerup, Denmark, January 10, 2025 – UNION therapeutics A/S (UNION), a privately held, clinical stage, pharmaceutical development company focused on immunology, today announced that CEO Dr. Kim Kjøller will present at the Dermatology Summit, January 12th 2025 at the Hyatt Regency